SRRA - Sierra Oncology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $0.12. This is a potential upside of $0.12 (0%) from yesterday's end of day stock price of $0.

Sierra Oncology's activity chart (see below) currently has 21 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 196.75 days.

Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 14-Apr-2022. First documented stock forecast 23-Oct-2017.

Best performing analysts who are covering SRRA - Sierra Oncology:

Jay Olson Joseph Pantginis Brian Cheng Maury Raycroft

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$55

$0.01 (0.02%)

$45

2 years 6 months 22 days ago
(14-Apr-2022)

5/6 (83.33%)

$0.25 (0.46%)

442

Hold

$39

$-15.99 (-29.08%)

$17

2 years 6 months 22 days ago
(14-Apr-2022)

2/3 (66.67%)

$-15.75 (-28.77%)

110

Hold

$55

$0.01 (0.02%)

$51

2 years 6 months 23 days ago
(13-Apr-2022)

2/3 (66.67%)

$0.25 (0.46%)

102

Buy

$39

$-15.99 (-29.08%)

$33

2 years 11 months 6 days ago
(30-Nov-2021)

3/3 (100%)

$15.71 (67.45%)

133

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SRRA (Sierra Oncology) average time for price targets to be met?

On average it took 196.75 days on average for the stock forecasts to be realized with a an average price target met ratio 79.17

Which analyst has the current highest performing score on SRRA (Sierra Oncology) with a proven track record?

JAY OLSON

Which analyst has the current lower performing score on SRRA (Sierra Oncology) with a proven track record?

MAURY RAYCROFT

Which analyst has the most public recommendations on SRRA (Sierra Oncology)?

Jay Olson works at OPPENHEIMER and has 6 price targets and 5 ratings on SRRA

Which analyst is the currently most bullish on SRRA (Sierra Oncology)?

Joseph Pantginis with highest potential upside - $0.01

Which analyst is the currently most reserved on SRRA (Sierra Oncology)?

Maury Raycroft with lowest potential downside - -$15.99

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?